Align Technology, Inc. (ALGN) has a MoatMap StockRank of 96/100 based on Quality (74/100), Value (42/100), and Momentum (72/100) factor scores. The current signal is STRONG BUY. Align Technology is a high-quality medical device pioneer, but it is currently facing cyclical consumer discretionary headwinds and lacks direct alignment with our active 18-month macro themes.
Align Technology is a global medical device company best known for its Invisalign system of clear aligners for orthodontic treatment, alongside its iTero intraoral scanners. The company holds a dominant market position in the clear aligner segment, protected by extensive intellectual property and a comprehensive ecosystem that includes treatment planning software and professional training. This strong brand recognition and innovative product portfolio establish a significant competitive moat in the dental aesthetics market.
| Price | $178.10 |
| Market Cap | $12.4B |
| P/E (TTM) | 28.24 |
| P/E (Forward) | 13.60 |
| Price/Book | 2.90 |
| Return on Equity | 10.8% |
| Return on Invested Capital | 13.6% |
| Debt/Equity | 2.80 |
| Gross Margin | 70.1% |
| Operating Margin | 16.6% |
| Revenue Growth | 6.2% |
| Free Cash Flow | $539M |
Align Technology, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).